| | | |   | | | | By Ed Silverman Adobe "This underscores what should be viewed as a national emergency,” said Adam Gaffney, a co-author of the analysis. Read More | | By Sarah Owermohle Ted S. Warren/AP Biden officials are bracing for the prospect that the sole preventive Covid therapy for immunocompromised people could soon be ineffective. Read More | | Sponsored Insight by ICON CLINICAL RESEARCH Maintaining the momentum in cell and gene therapy development In 2022, have been at least 11 CGTs pending approval in the US and six in the EU – how can drug developers maintain the momentum? Now is the time to lay the technical, regulatory, financial and logistical foundations that will embed CGT as a pivotal element of forward-looking health provision in years to come. Download this in-depth whitepaper to gain insights on the current market state and practicalities of clinical trials through long-term commercialization. | | By Andrew Joseph Kevin Dietsch/Getty Images Biden unveiled a new biodefense strategy, aiming to adapt lessons from the rocky response to Covid to prepare for future pandemics. Read More | | By Bob Herman Andrew Harnik/AP The DOJ is suing Cigna, alleging the insurer overcharged the federal government by purposefully inflating how sick its MA members were. Read More | |
No comments